Portal de datos abiertos de la Unión Europea - Custom query: Idioma filters: English; Temas filters: Población y sociedad, Educación, cultura y deportes; Formatos de los recursos filters: http://publications.europa.eu/resource/authority/file-type/HTMLtag:data.europa.eu,2012:/feeds/custom.atom?vocab_language=http%3A%2F%2Fpublications.europa.eu%2Fresource%2Fauthority%2Flanguage%2FENG&vocab_theme=http%3A%2F%2Fpublications.europa.eu%2Fresource%2Fauthority%2Fdata-theme%2FEDUC&res_format=http%3A%2F%2Fpublications.europa.eu%2Fresource%2Fauthority%2Ffile-type%2FHTML2023-10-03T09:11:26ZEuropean Publications Officehttps://data.europa.eu/euodpRecently created or updated datasets on Portal de datos abiertos de la Unión Europea. Custom query: Idioma filters: English; Temas filters: Población y sociedad, Educación, cultura y deportes; Formatos de los recursos filters: http://publications.europa.eu/resource/authority/file-type/HTMLThe Cultural and Creative Cities MonitorEuropean Commission, Joint Research Centre (JRC)mailto:marcos.dominguez-torreiro@ec.europa.eutag:data.europa.eu,2012:/dataset/0febda0d-66f8-4aef-b460-a6f89accc5a2The Cultural and Creative Cities Monitor is designed to help national, regional and municipal policy makers identify local strengths and opportunities and benchmark their cities against similar urban centres using both quantitative and qualitative data. The Cultural and Creative Cities Monitor is thus an instrument to promote mutual exchange and learning between cities. For researchers, the pool of comparable data is expected to generate new questions and insights into the role of culture and creativity in cities’ social and economic well being. 2023-10-03T09:11:26Z2022-08-22T12:02:44ZDrug-induced deaths in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-induced-deaths-in-europe-emcdda-2023-statistical-bulletinDrug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological indicator with two components at present: deaths directly caused by illegal drugs (drug-induced deaths) and mortality rates among problem drug users. These two components can fulfil several public health objectives, notably as an indicator of the overall health impact of drug use and the components of this impact, identify particularly risky patterns of use, and potentially identify new risks.
There are around **50 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T18:20:35Z2023-08-11T18:17:12ZDrug-related infectious diseases in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-related-infectious-diseases-in-europe-emcdda-2023-statistical-bulletinDrug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug users (IDUs) is low, other infectious diseases, such as hepatitis B/C, sexually transmitted diseases, TB, anthrax, tetanus, botulism, hepatitis A, HTLV may disproportionately affect drug users.
There are about **25 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T18:12:07Z2023-08-11T18:09:16ZDrug law offences in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-law-offences-in-europe-emcdda-2023-statistical-bulletinReports of offences against national drug legislation (use, possession, trafficking, etc.) reflect differences in law but also the different ways in which the law is enforced and applied, and the priorities and resources allocated to specific problems by criminal justice agencies. In addition, information systems on drug law offences/offenders vary considerably between countries, especially as regards recording procedures, definitions and statistical units.
There are around **30 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T18:05:10Z2023-08-11T18:04:19ZHealth and social responses to drug problems in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/health-and-social-responses-to-drug-problems-in-europe-emcdda-2023-statistical-bulletinHealth and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-, pharmacy- and non pharmacy-based programmes and on the number of syringes provided at these programmes.
2023-08-11T17:59:30Z2023-08-11T17:59:30ZDrug seizures in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-seizures-in-europe-emcdda-2023-statistical-bulletinData on drug seizures relate to all seizures made in each country during the year by all law enforcement agencies (police, customs, national guard, etc.). Caution is required in relation to double-counting that might occur within a country — although it is usually avoided — between various law enforcement agencies.
2023-08-11T17:53:58Z2023-08-11T17:50:21ZProblem drug use in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/2ff6ad28-019a-465a-986d-d59d2c88cda6‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular or long-term use of prescribed opioids such as methadone but does not include their rare or irregular use nor the use of other drugs, such as ecstasy or cannabis. Existing estimates of problem drug use are often limited to opioid and poly-drug use.
There are approximately **20 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (XLS/Excel format).2023-08-11T17:42:56Z2023-08-11T17:30:26ZPrice, purity and potency of drugs in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/price-purity-and-potency-of-drugs-in-europe-emcdda-2023-statistical-bulletinStreet prices of cannabis, heroin, cocaine and amphetamine are provided in euros per gram, of LSD in euros per unit/dose, and of ecstasy in euros per tablet. Data on prices come from a range of different sources, the comparability of which is not always known. Data on the potency of cannabis products and the purity of heroin (white and brown), cocaine products (cocaine and crack) and amphetamine are presented here. In addition, data on the MDMA content (weight in ecstasy tablets) is provided.
There are over **100 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T17:24:46Z2023-08-11T16:49:09ZDrug treatment demand in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-treatment-demand-in-europe-emcdda-2023-statistical-bulletin-duplicatedInformation on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and uptake of treatment facilities. ‘Treatment demand data’ come from each country with varying degrees of national coverage, principally from outpatient and inpatient centres’ treatment records.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T17:18:22Z2023-08-11T16:34:40ZPrevalence of drug use in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/prevalence-of-drug-use-in-europe-emcdda-2023-statistical-bulletinPrevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population under study. Interview surveys are based on self-report of participants regarding present and past behaviours, personal characteristics, knowledge and attitudes regarding drugs or other health topics.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T17:01:30Z2023-08-11T16:47:30ZGender Equality IndexEuropean Institute for Gender Equalityeige.sec@eige.europa.eutag:data.europa.eu,2012:/dataset/gender-equality-indexThe Gender Equality Index is a tool to measure the progress of gender equality in the EU, developed by EIGE. It gives more visibility to areas that need improvement and ultimately supports policy makers to design more effective gender equality measures.
The Gender Equality Index has tracked the painfully slow progress of gender equality in the EU since 2010, mostly due to advances in decision-making. While equality is more pronounced in some Member States than in others, it is far from a reality for everyone in every area. Gender norms around care, gender segregation in education and the labour market, and gender inequalities in pay remain pertinent.
The Index allows Member States to easily monitor and compare gender equality progress across various groups of women and men in the EU over time and to understand where improvements are most needed. The 2022 Index has a thematic focus on care in the Covid-19 pandemic. It explores the division of informal childcare, long-term care and housework between women and men.
The Gender Equality Index is a composite indicator. With a total of six core domains (work, money, knowledge, time, power and health) and two satellite domains (violence against women and intersecting inequalities), it offers a synthetic and easy-to-interpret measure for gender equality, indicating how far (or close) the EU and its Member States are from achieving gender equality on a scale of 1 to 100.
Building on previous editions alongside EIGE’s approach to ensuring intersecting inequalities are captured, the Gender Equality Index 2022 continues to show the diverse realities that different groups of women and men face. It examines how elements such as disability, age, level of education, country of birth and family type can intersect with gender and create many different kinds of pathways in people's lives.
2023-02-01T13:48:02Z2015-07-27T15:05:48ZDrug-related infectious diseases in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-related-infectious-diseases-in-europe-emcdda-2022-statistical-bulletinDrug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug users (IDUs) is low, other infectious diseases, such as hepatitis B/C, sexually transmitted diseases, TB, anthrax, tetanus, botulism, hepatitis A, HTLV may disproportionately affect drug users.
There are about **25 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2022-06-15T15:42:02Z2022-06-15T15:42:02ZDrug law offences in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-law-offences-in-europe-emcdda-2022-statistical-bulletinReports of offences against national drug legislation (use, possession, trafficking, etc.) reflect differences in law but also the different ways in which the law is enforced and applied, and the priorities and resources allocated to specific problems by criminal justice agencies. In addition, information systems on drug law offences/offenders vary considerably between countries, especially as regards recording procedures, definitions and statistical units.
There are around **30 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2022-06-15T14:52:06Z2022-06-15T14:50:46ZHealth and social responses to drug problems in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/health-and-social-responses-to-drug-problems-in-europe-emcdda-2022-statistical-bulletinHealth and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-, pharmacy- and non pharmacy-based programmes and on the number of syringes provided at these programmes.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2022-06-15T14:49:35Z2022-06-15T14:49:35ZDrug seizures in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-seizures-in-europe-emcdda-2022-statistical-bulletinData on drug seizures relate to all seizures made in each country during the year by all law enforcement agencies (police, customs, national guard, etc.). Caution is required in relation to double-counting that might occur within a country — although it is usually avoided — between various law enforcement agencies.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2022-06-15T14:46:53Z2022-06-15T14:46:53ZProblem drug use in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/problem-drug-use-in-europe-emcdda-2022-statistical-bulletin‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular or long-term use of prescribed opioids such as methadone but does not include their rare or irregular use nor the use of other drugs, such as ecstasy or cannabis. Existing estimates of problem drug use are often limited to opioid and poly-drug use.
There are approximately **20 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (XLS/Excel format).2022-06-15T14:43:32Z2022-06-15T14:43:32ZPrice, purity and potency of drugs in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/price-purity-and-potency-of-drugs-in-europe-emcdda-2022-statistical-bulletinStreet prices of cannabis, heroin, cocaine and amphetamine are provided in euros per gram, of LSD in euros per unit/dose, and of ecstasy in euros per tablet. Data on prices come from a range of different sources, the comparability of which is not always known. Data on the potency of cannabis products and the purity of heroin (white and brown), cocaine products (cocaine and crack) and amphetamine are presented here. In addition, data on the MDMA content (weight in ecstasy tablets) is provided.
There are over **100 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2022-06-15T14:00:38Z2022-06-15T14:00:38ZPrevalence of drug use in Europe (EMCDDA 2022 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/prevalence-of-drug-use-in-europe-emcdda-2022-statistical-bulletinPrevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population under study. Interview surveys are based on self-report of participants regarding present and past behaviours, personal characteristics, knowledge and attitudes regarding drugs or other health topics.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2022-06-15T13:58:25Z2022-06-15T13:58:25Z